Microbix Biosystems (TSX:MBX) Accounts Payable & Accrued Expense : C$1.88 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Accounts Payable & Accrued Expense?

Microbix Biosystems's quarterly accounts payable & accrued expense declined from Sep. 2023 (C$2.08 Mil) to Dec. 2023 (C$1.79 Mil) but then increased from Dec. 2023 (C$1.79 Mil) to Mar. 2024 (C$1.88 Mil).

Microbix Biosystems's annual accounts payable & accrued expense increased from Sep. 2021 (C$1.80 Mil) to Sep. 2022 (C$1.83 Mil) and increased from Sep. 2022 (C$1.83 Mil) to Sep. 2023 (C$2.08 Mil).

Microbix Biosystems Accounts Payable & Accrued Expense Historical Data

The historical data trend for Microbix Biosystems's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Accounts Payable & Accrued Expense Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.46

1.49

1.80

1.83

2.08

Microbix Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.73	2.52	2.08	1.79	1.88

Microbix Biosystems Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Microbix Biosystems (TSX:MBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

James Stuart Currie

Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines